The opportunity for Nuheara to build a significant business can be summarised as
follows:
(a) the Wearables market is projected to rapidly grow over the next 5 years
with many industry research bodies predicting strong consumer and
enterprise adoption;
(b) Wearables innovation is expected to move from the wrist to other parts of
the body including the ear (i.e. Hearables);
(c) according to independent market research company eMarketer Inc, it is
anticipated that approximately 2.56 billion smartphones will be in
circulation by 2018 and many consumers will require a hearing device to
connect to their smartphone;
(d) Nuheara's opportunity is global in scale and not restricted to any particular
geography. Nuheara has the added benefit of its co-founders being colocated
in Australia and the USA;
(e) technology adoption is moving rapidly to a voice-enabled world where
consumers interact with their smart devices with their voice – Nuheara is
placed to be one of the best-of-breed hearing platforms to enable this
adoption;
(f) Nuheara's aim is to make its IQbudsTM the platform of choice for the world's
voice enabled software developers. Nuheara expects to release a software
development kit to third party app developers. For example, this could
include Hearables apps such as translating languages on the fly and personal
tour or sightseeing guides;
(g) the technology team at Nuheara are world class audio digital signal
processing technologists and have a proven background in inventing and
building complex audio technology devices; and
(h) the co-founders of Nuheara have a history of building global technology
companies and this will be the second hearing technology business they have
developed.
- Forums
- ASX - By Stock
- WAC
- Ann: Disclosure Document
Ann: Disclosure Document, page-7
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WAC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online